20247 ⎘
Medicinal preparations containing organic active ingredients; Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids; Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#1202METHOD FOR SUPERVISING CONSUMPTION OF A MEDICAL FOOD FOR PREVENTION AND/OR MANAGEMENT OF A DISEASE OR CONDITION
#1203Compositions and methods for treating chronic inflammation and inflammatory diseases
#1204Compositions and methods for diagnosis and treatment of metabolic syndrome
#1205Ester of a Phospholipid With Conjugated Linoleic Acid for the Treatment of Psychiatric Disorders With Neuroinflammatory and Neurodegenerative Basis
#1206Process for Producing a Soft Gel Capsule Comprising Viable Probiotic Bacteria and a Soft Gel Capsule Comprising Viable Probiotic Bacteria Having a Long Shelf Life
#1207Self-micellizing fatty acids and fatty acid ester compositions and their use in the treatment of disease states
#1208ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#1209Diabetes control using postprandial feedback
#1210Omega-3 compositions, dosage forms, and methods of use
#1211Edible, retrievable animal items
#1212Bioeffective krill oil compositions
#1213PHARMACEUTICAL PRODUCT, MEDICAL FOOD OR DIETARY SUPPLEMENT FOR PREVENTING CANCER AND INFLAMMATORY DISEASES
#1214Methods, compositions, and devices for supplying dietary fatty acid needs
#1215Methods, compositions, and devices for supplying dietary fatty acid needs
#1216Bioeffective krill oil compositions
#1217Bioeffective krill oil compositions
#1218Methods of treating a poikilothermic organism in a decreasing temperature environment
#1219Flavored Water Composition For Pets
#1220NUTRITIONAL COMPOSITION WITH LOW CONTENT OF MEDIUM-CHAIN FATTY ACIDS IN SPECIFIC PROPORTIONS, AND ITS USES
#1221PHOSPHOLIPID-CONTAINING MARINE EXTRACTS FOR TREATMENT OF CARDIOVASCULAR DISEASES
#1222Aromatic farnesyl compound and application thereof
#1223Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
#1224METHOD OF PRODUCING EGG YOLK BASED FUNCTIONAL FOOD PRODUCT AND PRODUCTS OBTAINABLE THEREBY
#1225METHODS FOR MODULATING IKS CHANNEL ACTIVITY
#1226Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1227Compounds and methods for modulating vascular injury
#1228Lipid comprising long chain polyunsaturated fatty acids
#1229PRODUCTION OF OMEGA 3 FATTY ACIDS BY RECOMBINANT ESCHERICHIA COLI NISSLE 1917
#1230Dietary supplement compositions for cardiovascular health
#1231Method of manufacturing enteric soft capsule
#1232COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
#1233BIPOLAR TRANS CARTENOID SALTS AND THEIR USES
#1234METHODS FOR TREATING MULTIPLE SCLEROSIS
#1235PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#1236Probiotic sports nutrition compositions
#1237Treatment and Prevention of Liver Disease Associated with Parenteral Nutrition (PN)
#1238Probiotic confection and lipid compositions
#1239Methods and compositions comprising 10-hydroxy-2-decenoic acid
#1240Low protein infant formula with increased essential amino acids
#1241Method
#1242Glycerophospholipids for the improvement of cognitive functions
#1243Composition for preventing or treating muscle wasting-related disease and use thereof
#1244Compositions comprising 15-HEPE and methods of using the same
#1245Composition for Treatment of Skin
#1246COMPOSITIONS AND METHODS FOR THE PREVENTION AND OR TREATMENT OF SCHISTOSOMIASIS
#1247Transgene construct encoding delta 12 fatty acid
#1248PHARMACEUTICAL FORMULATIONS FOR TREATING SKIN DISORDERS AND METHODS FOR FABRICATING AND USING THEREOF
#1249Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1250Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
#1251Nutritional composition for improving muscle function and daily activity
#1252Method for reducing white matter lesions, white matter hyperintensities (WMH), leukoaraiosis or periventricular white matter disease in elderly
#1253METHOD FOR TREATING, STABILIZING OR SLOWING DOWN BRAIN GLUCOSE METABOLISM DEFICIT
#1254GUMMY COMPOSITIONS FOR NUTRITIONAL SUPPLEMENTATION
#1255Medicinal composition of extract of seed of emblica officinalis and method of preparing the same
#1256Composition for lowering blood lipids and use thereof
#1257Composition for preventing the occurrence of cardiovascular event in multiple risk patient
#1258USE OF LEUKOTRIENE B4 IN COMBINATION WITH A TOLL-LIKE RECEPTOR LIGAND, A RIG-I-LIKE RECEPTOR LIGAND, OR A NOD-LIKE RECEPTOR LIGAND TO ENHANCE THE INNATE IMMUNE RESPONSE
#1259Infant nutrition for improving fatty acid composition of brain membranes
#1260METHODS OF REDUCING OR PREVENTING OXIDATION OF SMALL DENSE LDL OR MEMBRANE POLYUNSATURATED FATTY ACIDS
#1261Semifluorinated alkane compositions
#1262PAIN RELIEF COMPOSITION
#1263METHOD AND COMPOSITIONS FOR TREATING CHRONIC INFLAMMATORY DISORDERS
#1264Methods for improving muscle and heart function
#1265COMPOSITIONS AND METHODS FOR REDUCING A FATTY ACID DESATURATION INDEX IN A SUBJECT IN NEED THEREOF
#1266Fatty acid formulations and methods of use thereof
#1267Botanical formulations
#1268Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof
#1269PHARMACEUTICAL COMPOSITIONS OF BERBERINE WITH EPA AND DHA, AND METHODS THEREOF
#1270Method for treating neurotrauma
#1271COMPOSITIONS AND METHODS FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE
#1272UCP-1 expression promoter
#1273Stable pharmaceutical composition and methods of using same
#1274DIETARY COMPOSITION FOR IMPROVED PERFORMANCE
#1275All-natural enteric soft capsules
#1276Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
#1277SOLID FORMULATIONS CONTAINING OMEGA-3 AND RESVERATROL
#1278MICROCAPSULES COMPRISING A FAT-SOLUBLE ACTIVE SUBSTANCE
#1279COMPOSITIONS, KITS AND METHODS FOR NUTRITION SUPPLEMENTATION
#1280Flavonoid compositions and methods of use
#1281ORAL VETERINARY PHARMACEUTICAL AND NUTRACEUTICAL COMPOSITIONS
#1282Methods of treating ototoxicity
#1283Enteral feeding device and related methods of use
#1284Compositions comprising eicosapentaenoic acid and a hydroxyl compound and methods of use thereof
#1285Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids
#1286Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
#1287Dietary and nutritional compositions and methods of use
#1288Lipid compositions with high DHA content
#1289Intermittent fibrate administration method
#1290Flavonoid compositions and methods of use
#1291COMPOSITION FOR REDUCING NEW-ONSET DIABETES
#1292Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
#1293Bioactive agents included in functionalized starch having a single helix V-structure
#1294PHARMACEUTICAL COMPOSITIONS COMPRISING DGLA AND USE OF SAME
#1295Krill oil preparations and their uses
#1296Compositions and methods for treating a pathogenic metabolic condition of the gut microbiota and derived diseases
#1297COMPOSITIONS CONTAINING AS THE ACTIVE INGREDIENT COMPONENTS FROM SALVIA SCLAREA SEED
#1298TYPE A GELATIN CAPSULE CONTAINING PUFA IN FREE ACID FORM
#1299TUBE FEED FORMULATIONS AND METHODS FOR USING SAME
#1300Methods for improving health of farmed fish
#1301Fast acting joint relief formulations
#1302Topical film delivery system
#1303Topical film delivery system
#1304UNSATURATED FATTY ACID ABSORPTION ACCELERATOR
#1305Preparation for improving the action of receptors
#1306COMPOSITION FOR BRAIN IMPROVEMENT
#1307INTESTINAL BARRIER INTEGRITY
#1308COMPOSITION FOR PREVENTING OR IMPROVING PERIPHERAL NEUROPATHY
#1309Use of derivatives of polyunsaturated fatty acids as medicaments
#1310Eicosapentaenoic acid (EPA) formulations
#1311FOOD MATRICES AND METHODS OF MAKING AND USING
#1312Method for assessing and treating or preventing impaired plasma polar lipid levels
#1313Methods, compositions, and devices for supplying dietary fatty acid needs
#1314Phytocomplexes exhibiting multiple, synergistic antioxidant activities useful in foods, dietary supplements, cosmetics and pharmaceutical preparations
#1315Compositions Comprising 15-HEPE and Methods of Treating or Preventing Cancer and Neurologic Disease
#1316PROPHYLACTIC USE OF NEUROPROTECTANTS IN SPORTS-RELATED TRAUMATIC BRAIN INJURY
#1317COMPOSITIONS AND METHODS FOR REDUCING CHRONIC LOW-LEVEL INFLAMMATION
#1318Compositions comprising polyunsaturated fatty acid monoglycerides or derivatives thereof and uses thereof
#1319Methods of treating mixed dyslipidemia
#1320Nutritional compositions containing phosphatidylethanolamine, sphingomyelin and docosahexaenoic acid
#1321Compositions and methods for treating non-alcoholic steatohepatitis
#1322Metabolism-improving agent comprising rare fatty acid
#1323Composition and method to alleviate joint pain using phospholipids and astaxanthin
#1324Materials, methods and devices for altering cell reactivity
#1325Nutritional compositions and methods for promoting cognitive development
#1326FOOD COMPOSITION
#1327Dietary supplements and formulations
#1328ANTI-INFLAMMATORY AGENT CONTAINING RARE FATTY ACID
#1329Dihomo-γ-linolenic acid-containing microbial oil and dihomo-γ-linolenic acid-containing microbial biomass
#1330COMPOSITION INVOLVED IN REGULATING ENERGY CYCLE, INFLAMMATION AND INSULIN RESISTANCE DYSFUNCTIONS, AND USE THEREOF PARTICULARLY IN CARDIOMETABOLIC DISEASES
#1331Composition for Treatment of Mold
#1332Eicosapentaenoic acid-producing microorganisms, fatty acid compositions, and methods of making and uses thereof
#1333COMPOSITION FOR TREATMENT OF NAFLD
#1334Serine glycerophospholipid preparation and method for treatment of seizures
#1335GELLING AGENT-BASED DOSAGE FORM
#1336Oral delivery compositions for treating dermatitis disorders in mammals
#1337Method for decreasing visceral fat or increasing energy consumption
#1338FAD4, FAD5, FAD5-2, AND FAD6, NOVEL FATTY ACID DESATURASE FAMILY MEMBERS AND USES THEREOF
#1339EFFICACY OF DIETARY DHA-PHOSPHOLIPID FOR BRAIN DHA AND DPA ACCRETION IN NEONATES
#1340Use of a composition comprising fish oil and juice for the treatment of inflammation
#1341Compositions comprising oxo-derivatives of fatty acids and methods of making and using same
#1342COMPOSITIONS OF POLYUNSATURATED FATTY ACIDS AND METHODS OF USE THEREOF
#1343Factors for the production and accumulation of polyunsaturated fatty acids (PUFAS) derived from PUFA synthases
#1344Combined acetylcholinesterase inhibitor and quaternary ammonium antimuscarinic therapy to alter progression of cognitive diseases
#1345METHODS OF TREATING OR PREVENTING VASCULAR DISEASES OF THE RETINA
#1346Therapeutic methods
#1347Method and apparatus for the manufacture of softgels
#1348Non-Allergenic Ingredients and Food Products
#1349Systems and methods for thrombosis prevention
#1350Composition Comprising a Uridine Source, an Omega-3 PUFA for Improving Coordination, Balance, Grip Strength or Fine Motor Skills
#1351COMPOSITIONS OF OMEGA 3 FATTY ACIDS TO TREAT DISEASES WHICH INVOLVE DAMAGE TO THE NERVOUS SYSTEM
#1352PHARMACEUTICAL COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF TREATING ASTHMA AND LUNG DISORDERS USING SAME
#1353Topical compositions comprising polyunsaturated fatty acids
#1354DIET FOOD COMPOSITION INCLUDING DHA TO REDUCE SHORT-TERM AND LONG-TERM LOW-GRADE INFLAMMATION
#1355Compositions and methods for diagnosis and treatment of metabolic syndrome
#1356Visual performance and/or macular pigmentation
#1357NUTRITIONAL COMPOSITION COMPRISING HYDROLYZED PROTEIN
#1358Nutritional composition
#1359Microbial oil, production method for microbial oil, concentrated microbial oil, and production method for concentrated microbial oil
#1360Compositions for enhancing immune function in a pediatric subject
#1361Processes for obtaining microbial oil from microbial cells
#1362Solid solution compositions and use in chronic inflammation
#1363BIOCONJUGATE MOLECULES WITH BIOLOGICAL AND TECHNO-FUNCTIONAL ACTIVITY, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF
#1364Compositions with high content of sesamin class compounds
#1365COMPOSITION COMPRISING FERRIC SACCHARATE AND HIGH CONCENTRATIONS OF MICROENCAPSULATED LC-PUFA WITH A REDUCED OFF TASTE
#1366NUTRITION, EXERCISE AND COGNITIVE DEVELOPMENT
#1367Water-Dispersible Supplements and Methods
#1368COMPOSITIONS AND METHODS FOR USING SAME FOR REDUCING LEVELS OF ARACHIDONIC ACID IN TISSUE HAVING UNDERGONE AN INVASIVE PROCEDURE
#1369Thraustochytrids, fatty acid compositions, and methods of making and uses thereof
#1370Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#1371Composition and method to alleviate joint pain using low molecular weight hyaluronic acid and astaxanthin
#1372Pyrimidine derivative and a fatty acid source for use in the treatment of constipation
#1373Omega-3 fatty acid articles of manufacture, and methods and apparatus for making same
#1374Anti-inflammatory omega-3 synergistic combinations
#1375Solid solution compositions and use in chronic inflammation
#1376Lipid composition for the prevention or treatment of skin problems
#1377Improving the level of hydration in a cat
#1378Liquid milk fortifier composition with relatively high lipid content
#1379METHODS FOR IMPROVEMENT IN SEXUAL HEALTH AND THE COMPOSITIONS USED THEREIN
#1380MACROALGAE COMPOSITIONS, PROCESSES FOR PREPARATION THEREOF, AND USES IN SPORTS NUTRITION
#1381Compositions and methods for treating a pathogenic metabolic condition of the gut microbiota and derived diseases
#1382Methods and compositions for improving kidney function
#1383Bioeffective krill oil compositions
#1384Antibiotic composition comprising a chemotactic agent and a nutrient dispersion
#1385Bioeffective krill oil compositions
#1386USE OF NUTRITIONAL COMPOSITIONS INCLUDING NATURAL VITAMIN E, AND POLYUNSATURATED FATTY ACID
#1387Second Generation Fatty Acid Compositions, Formulations, and Methods of Use and Synthesis Thereof
#1388Food Compositions Containing All Essential Nutrients
#1389INGESTIBLE COMPOSITIONS AND PROCESSES OF PREPARATION
#1390Modulators of androgen synthesis
#1391Dietary supplement containing alkaline electrolyte buffers
#1392Topical pharmaceutical composition of acitretin
#1393Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders
#1394COMPOSITION AND METHOD TO ALLEVIATE JOINT PAIN USING PHOSPHOLIPIDS AND ROE EXTRACT
#1395Nanoparticle compositions and methods as carriers of nutraceutical factors across cell membranes and biological barriers
#1396Oil/fat composition containing polyunsaturated fatty acid
#1397Topical formulations and uses thereof
#1398Topical formulations and uses thereof
#1399FATTY ACID COMPOSITION AND PLANT EXTRACT AND PHARMACEUTICAL PREPARATION AND APPLICATION THEREOF
#1400Nutritional formulations using human milk oligosaccharides for modulating inflammation
#1401Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases
#1402Compositions and methods for epigenetic regulation of long chain polyunsaturated fatty acid production
#1403COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF METABOLIC STEATOSIS AND STEATOHEPATITIS
#1404Omega-3 compositions, dosage forms, and methods of use
#1405Methods and products to provide oral nutritional care to subjects with dementia
#1406OMEGA-3 FATTY ACID ESTER COMPOSITIONS
#1407Dietary supplements and formulations
#1408LIPID EXTRACT OF PASSIFLORA SEEDS
#1409COMPOSITIONS CONTAINING PUFA, URIDINE AND CHOLINE AND METHODS OF USE THEREOF
#1410COMPOSITIONS AND METHODS FOR LOWERING TRIGLYCERIDES
#1411Microencapsulated omega-3 oil powder for animal feed
#1412APPARATUS, SYSTEM AND METHOD FOR THE TREATMENT OF ATHEROSCLEROSIS, HEART DISEASE AND STROKE
#1413Dietary supplements for treating ADHD and related disorders
#1414Stable pharmaceutical composition and methods of using same
#1415COMPOSITIONS USEFUL IN THE PREVENTION OR TREATMENT OF SKIN CANCER
#1416MODULATORS OF IL-12 AND/OR IL-23 FOR THE PREVENTION OR TREATMENT OF ALZHEIMER'S DISEASE
#1417METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION OF PROTEINS
#1418THERAPEUTIC AGENT FOR DYSLIPIDEMIA
#1419STABILIZED FORMULATIONS OF FATTY ACIDS
#1420Composition comprising a lipid compound, a triglyceride, and a surfactant, and methods of using the same
#1421Delivery and Controlled Release of Encapsulated Lipophilic Nutrients
#1422Methods for the production of diatom biomass
#1423Trans carotenoids, their synthesis, formulation and uses
#1424Compositions containing enriched natural crocin and/or crocetin, and their therapeutic or nutraceutical uses
#1425Mineral amino-acid complexes of active agents
#1426Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
#1427Solid solution compositions and use in chronic inflammation
#1428Method for detecting risk factor for metabolic syndrome or hyperferritinemia
#1429Multi-supplement compositions
#1430Method for treating metabolic syndrome
#1431Heptadecanoic acid supplement to human diet
#1432Use of heptadecanoic acid (C17:0) to detect risk of and treat hyperferritinemia and metabolic syndrome
#1433COMPOSITIONS CONTAINING NON-POLAR COMPOUNDS
#1434Compositions comprising 15-HEPE and methods of treating or preventing fibrosis using same
#1435Compositions and methods for the treatment of cancer
#1436Lipid compositions comprising triacylglycerol with long-chain polyunsaturated fatty acids at the sn-2 position
#1437Direct application system and method for the delivery of bioactive compositions and formulations
#1438USE OF NUTRITIONAL COMPOSITIONS WITH PHOSPHOLIPID SPHINGOLIPID AND CHOLESTEROL
#1439NEW KETOGENIC DIET AND ITS USE IN TREATING THE CRITICALLY ILL
#1440Kits and methods for nutrition supplementation
#1441Compositions, methods and kits for treating cancer
#1442Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid particles encapsulating lipids using said microorganisms
#1443Omega-3 fatty acid ester compositions unitary pharmaceutical dosage forms
#1444Glyceride Composition
#1445Compositions and methods for treating chronic inflammation and inflammatory diseases
#1446Use of derivatives of polyunsaturated fatty acids as medicaments
#1447Use of derivatives of polyunsaturated fatty acids as medicaments
#1448Nutritional composition for improving brain function in phenylketonuria
#1449FRUIT SNACKS FORTIFIED WITH POLYUNSATURATED FATTY ACIDS
#1450Active implantable device suitable for use in an MRI scanner
#1451Nitrated lipids and methods of making and using thereof
#1452Use of DHA, EPA or DHA-derived EPA for treating a pathology associated with cellular oxidative damage
#1453Self-emulsifying composition of ω3 fatty acid
#1454THERAPEUTIC ASTAXANTHIN AND PHOSPHOLIPID ROE EXTRACT COMPOSITION AND ASSOCIATED METHOD
#1455Composition for the treatment of progressive renal diseases
#1456Compositions and methods for treating or preventing obesity in a subject in need thereof
#1457ADMINISTRATION OF A FOOD COMPOSITION PRODUCT
#1458COHESIVE LIQUID BOLUS COMPRISING BIOACTIVES
#1459Nutritional supplements containing a peptide component and uses thereof
#1460LOW DOSE ORAL PHARMACEUTICAL COMPOSITION OF ISOTRETINOIN
#1461DIETARY OMEGA-3 FATTY ACID DERIVED GLYCEROPHOSPHOLIPIDS TO TREAT NEUROPATHIC PAIN
#1462METHODS AND COMPOSITIONS FOR TREATING OR PREVENTING ATTENTION DEFICIT HYPERACTIVITY DISORDER
#1463Methods of producing algal cell cultures and biomass, lipid compounds and compositions, and related products
#1464Compositions and methods for the treatment of inflammatory bowel disease
#1465Lipid scavenging in Ras cancers
#1466Method and apparatus for the manufacture of softgels
#1467COMPOSITIONS COMPRISING PLANT PROTEINS AND METHODS FOR PREVENTION OF METABOLIC AND CARDIOVASCULAR PATHOLOGIES IN PATIENT WITH CARDIOMETABOLIC RISK, INCLUDING HYPERGLYCEMIA
#1468Combination comprising an omega-3 fatty acid composition and an SGLT2 inhibitor
#1469Methods of improving reproductive and respiratory health
#1470Methods to inhibit infection during wound healing with topical compositions including amino acids
#1471METHODS FOR MAKING RETINOIDS AND USES THEREOF
#1472PHARMACEUTICAL PRODUCT, MEDICAL FOOD OR DIETARY SUPPLEMENT FOR PREVENTING CANCER AND INFLAMMATORY DISEASES
#1473Method for stimulating the intestinal flora
#1474Prepared foods having high efficacy omega 6/omega 3 balanced polyunsaturated fatty acids
#1475Method of reducing appetite in a human subject comprising administering krill oil composition
#1476COMPOSITIONS CONTAINING OMEGA-3 OIL AND USES THEREOF
#1477FOOD AND DRINK
#1478LIQUID CONCENTRATED FORMULA
#1479PROPHYLACTIC USE OF NEUROPROTECTANTS IN SPORTS-RELATED TRAUMATIC BRAIN INJURY
#1480Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
#1481Oral pharmaceutical composition of isotretinoin
#1482Metabolic imprinting effects of specifically designed lipid component
#1483NUTRITIONAL OR DIETARY SUPPLEMENTS CONTAINING FATTY ACIDS AND NITRITE
#1484Pre-spray emulsions and powders containing non-polar compounds
#1485Anti-aging skin care compositions and regimens
#1486Intestinal barrier integrity
#1487THERAPEUTIC OR PROPHYLACTIC AGENT FOR CORNEAL EPITHELIUM DISORDERS AND/OR CONJUNCTIVAL EPITHELIUM DISORDERS
#1488Internal composition
#1489Use of a composition comprising fish oil and juice for the treatment and/or post treatment of cancer
#1490Acyltransferases and uses thereof in fatty acid production
#1491PLANT EXTRACTS AND RELATED COMPOSITIONS, METHODS AND SYSTEMS
#1492METHOD FOR STIMULATING INTESTINAL BARRIER INTEGRITY AFTER NON-NATURAL BIRTH
#1493COMPOSITION AND METHOD TO IMPROVE BLOOD LIPID PROFILES AND OPTIONALLY REDUCE LOW DENSITY LIPOPROTEIN (LDL) PER-OXIDATION IN HUMANS
#1494Composition for external use on skin for inflammatory diseases
#1495OPHTHALMIC COMPOSITIONS WITH OMEGA-3 FATTY ACIDS
#1496Reperfusion with omega-3 glycerides promotes donor organ protection for transplantation
#1497COMPOSITION AND/OR METHOD FOR PREVENTING ONSET AND/OR RECURRENCE OF CARDIOVASCULAR EVENTS
#1498Therapeutic target for the treatment of cancers and related therapies and methods
#1499COMPOSITE FORMULATION COMPRISING A FILM COATING LAYER CONTAINING ROSUVASTATIN OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF
#1500Composition for reducing blood lipid and use thereof as healthcare dietary supplements